Downloads: 0 | Views: 180
Informative Article | Biological Sciences | India | Volume 11 Issue 6, June 2022 | Popularity: 4.1 / 10
Leprosy Patients with COVID-19: The Double Trouble?
Anuj Mavlankar
Abstract: Type 2 leprosy reaction or Erythema nodosum leprosum in conjunction with COVID-19 poses a higher risk for patients with a long course of corticosteroids for its control. Despite regular uptake of corticosteroids, the benefits will usually outweigh the small increase in acquiring SARS-CoV-2 infection. In addition, the actual consequences of M. leprae-SARS-CoV-2 co-infection must be thoroughly investigated. Further detailed work should be done to unleash the factors associated with COVID-19 and their possible correlation with leprosy patients.
Keywords: Leprosy, COVID-19, Erythema nodosum leprosum, Type-2 leprosy reaction, corticosteroids
Edition: Volume 11 Issue 6, June 2022
Pages: 1282 - 1285
DOI: https://www.doi.org/10.21275/SR22617123624
Make Sure to Disable the Pop-Up Blocker of Web Browser